Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 2Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 1854Neoplasms 1242Colorectal Neoplasms 1049Carcinoma, Non-Small-Cell Lung 1001Stomach Neoplasms 798Carcinoma, Hepatocellular 781Lung Neoplasms 759Prostatic Neoplasms 690Pancreatic Neoplasms 571Rectal Neoplasms 445Neoplasm Metastasis 404Ovarian Neoplasms 401Colonic Neoplasms 401Uterine Cervical Neoplasms 399Recurrence 382Leukemia, Myeloid, Acute 370Esophageal Neoplasms 355Multiple Myeloma 339Lymphoma 333Head and Neck Neoplasms 328Melanoma 307Precursor Cell Lymphoblastic Leukemia-Lymphoma 289Brain Neoplasms 264Urinary Bladder Neoplasms 250Nasopharyngeal Carcinoma 222Liver Neoplasms 221Leukemia 218Lymphoma, Large B-Cell, Diffuse 215Polycystic Ovary Syndrome 208Squamous Cell Carcinoma of Head and Neck 203

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Pseudomonas Infections × Clear all
NCT05975151 2023-09-21

Efficacy and Safety of Pseudomonas Aeruginosa for Intermediate and High-risk Non-muscle Invasive Bladder Cancer

Qilu Hospital of Shandong University

Phase 2 Unknown
63 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Pseudomonas Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡